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The intestinal epithelium possesses a remarkable ability for both proliferation
and regeneration. The last two decades have generated major advances in our
understanding of the stem cell populations responsible for its maintenance
during homeostasis and more recently the events that occur during injury
induced regeneration. These fundamental discoveries have capitalised on the use
of transgenic mouse models and in vivo lineage tracing to make their conclusions.
It is evident that maintenance is driven by rapidly proliferating crypt base stem
cells, but complexities associated with the technicality of mouse modelling have
led to several overlapping populations being held responsible for the same
behaviour. Similarly, it has been shown that essentially any population in the
intestinal crypt can revert to a stem cell state given the correct stimulus during
epithelial regeneration. Whilst these observations are profound it is uncertain
how relevant they are to human intestinal homeostasis and pathology. Here,
these recent studies are presented, in context with technical considerations of the
models used, to argue that their conclusions may indeed not be applicable in
understanding “homeostatic regeneration” and experimental suggestions
presented for validating their results in human tissue.
Key words: Intestinal stem cell; Plasticity; Lgr5; Regeneration
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Core tip: Recent advances, using transgenic mice, in understanding cellular hierarchies in
the intestinal epithelium have identified numerous cell populations which retain the
ability to change their fate in response to injury. Here, these new studies are presented in
the context of a discussion about what represents a relevant epithelial injury to
understand ‘homeostatic regeneration’. Experimental suggestions are proposed for
validating animal findings to translate our current knowledge to better understand human
intestinal epithelial maintenance.
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The intestinal lining is one of the most rapidly proliferating epithelia in humans. In
the small intestine this single-cell thick structure is thrown into folds consisting of villi
that protrude into the lumen and crypts that are embedded in the intestinal wall. The
colonic epithelium is similar although lacks villi.  At a histological level the small
intestine and colon are also alike. In the small intestine the most prevalent cell type is
the absorptive enterocyte and, in the colon, the colonocyte. Both organs also possess
secretory goblet, enteroendocrine and tuft cells (Figure 1). The main cellular difference
between the small intestine and colon is the presence of secretory Paneth cells. These
long-lived secretory and niche cells are only found in the bottom of small intestinal
crypts and rarely found in the normal colon. A functionally similar cell type, termed
the deep crypt secretory cell, has however recently been shown to exist in colonic
crypts[1,2]. Both epithelia are highly proliferative and retain a remarkable ability for
regeneration following injury. Homeostatic proliferation throughout the intestine
takes place in the bottom of the crypts, being most active in the so-called transit am-
plifying zone – an area directly above the crypt base. Differentiation occurs as cells
migrate up the crypts onto either villi or the colonic mucosal plateau.
Over the last two decades the intestine has become an area of great interest in stem
cell  biology  and  is  arguably  the  prototypical  organ  for  the  study  of  epithelial
homeostasis and regeneration partly due to the unique structure of the crypt that
facilitates ready quantification of stem cell clonogenicity. Following seminal findings
using lineage tracing, of the clonogenic function of undifferentiated crypt cells during
homeostasis, the concept of cellular plasticity has more recently been explored using
contemporary in  vivo  techniques.  Plasticity  is  defined as  a  change in  cell  fate  in
response to a stimulus. The results of these new studies have however led the field
into a complex and confusing period where, on face value, it appears that almost any
cell  type in the intestinal  epithelium can revert  to  a  stem cell  state  during rege-
neration. In this opinion review I discuss both the important original and more recent
studies and propose that whilst the findings are striking they may not be entirely
relevant  for  our  understanding  of  “homeostatic  regeneration”.  Here,  I  define
homeostatic regeneration as the cellular changes that occur during the response to
injury classically occurring during mammalian life and commonly encountered path-
ologies.
Evidence for the existence of intestinal stem cells was first demonstrated in the
1970s by Cheng and Leblond who showed that  after  treating mice with tritiated
thymidine,  crypt  base  columnar  cells  (CBCs)  developed  labelled  phagosomes
following phagocytosis  of  nearby non-viable cells[3].  Subsequent tracing of  these
labelled phagosomes over time found they were inherited by all the differentiated cell
types of the epithelium. These experiments proposed that stem cells present in the
base of intestinal crypts could generate all the differentiated cell types of the intestinal
epithelium. Following this, attention focussed on cells in the so-called +4 position that
appeared both quiescent and undifferentiated – a feature commonly found in stem
cells in other organs[4]. The field however underwent a sea change in 2007 following
the publication from Hans Clevers’ laboratory demonstrating that Lgr5 expression
marked rapidly  proliferating CBCs in  the  small  intestine  and colon which were
capable of profound clonal capacity as shown using a lineage tracing technique in
mice[5]. This highly elegant study provided the first direct proof that rapidly cycling
Lgr5+ CBCs were the bona fide homeostatic stem cells of throughout the intestine.
There then followed a period of intense debate about the nature of the +4 cell with
several groups showing marker overlay of genes of interest with cells in this position
also possessing stem cell capacity including Bmi1, Hopx and mTert[6-8]. Interestingly,
like the original Barker et al[5]  study, all  three of these studies primarily used the
location of promoter driven reporter expression to define the anatomical location of
cells expressing the respective gene of interest. It is however unknown what degree of
gene activity is required to drive reporter expression and this can be compounded by
the introduction of Cre recombinase as a conditional activator of reporter expression
as is often used in lineage tracing studies. Highlighting these issues, two separate
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Figure 1
Figure 1  Schematic of the arrangement of cells in the small intestine. CBC: Crypt base columnar cell; LRC:
Label retaining cell.
studies of Bmi1 expressing cells using different models; Bmi1-CreER and Bmi1-GFP
(both knocked in at the endogenous locus) show different results with one study
finding the cells to be stem cells and the other mature enteroendocrine cells[6,9]. The
Cre enzyme is also seen to possess apparent regional differences in expression when
under the control of reportedly pan intestinal promoters; Cre is often found to have
greater activity the more proximal in the intestinal tract making it hard to compare
with stem cell behaviour in the distal small intestine and colon[10,11]. Whether this is
due to promoter, enzyme intrinsic or reporter differences is incompletely understood.
These concerns can be compounded when a CreER system is used to drive conditional
recombination. In this situation off-target effects of both tamoxifen and impaired stem
cell function following activation of Cre have been reported by two separate stu-
dies[12,13]. These important studies indicate that quantification of stem cell behaviour
following tamoxifen driven Cre activation may not be accurate or representative of
the true in vivo situation.
Tissue specific gene promoters can also have problems with both sensitivity and
specificity for all cells on the crypt-villus axis. A comparison between two intestinal,
reportedly pan-epithelial  Cre models,  Villin-Cre  and Ah-Cre  showed unexpected
variation in the Ah-Cre driven recombination that failed to target a cell population that
was capable of driving regeneration[14]. Previously the Ah-Cre model had been repo-
rted to induce recombination in all IECs other than terminally differentiated Paneth
cells[10]. However, in the study by Parry et al[14] the authors found that Ah-Cre also
failed  to  induce  recombination  in  a  non-Paneth  cell  putative  reserve  stem  cell
population. The implication of this work is that quantifying global clonal output using
Ah-Cre driven reporters may not include all potentially clonogenic populations and
erroneous conclusions could be drawn.
It is also unknown how long reporter proteins persist and are visible for, following
cessation of their production. It is likely that different reporters have varying stability
that could confound analysis if induced conditionally and thus temporally where ex-
pression may still be visualised in daughter cells that aren’t expressing the mRNA of
the gene of  interest.  This  may lead to an assumption that  reporter  expression is
directly correlated with gene expression which has not definitively be proven. Cells
may  also  express  low  levels  of  the  gene  of  interest  and  still  possess  the  same
functionality as those with high levels of expression (as the marker itself is unlikely to
directly  drive function)  but  low expressors  may fail  to  be identified by reporter
expression. Indeed, precisely these concerns were found valid when bulk gene ex-
pression comparisons were used to compare the transcriptome of CBC Lgr5+ cells
with +4 located Bmi1+ cells suggesting that these cells are in reality one and the same
and the +4 cell may well be Lgr5 expressing[15]. Cumulatively, all these early studies
certainly provide direct evidence that homeostatic stem cells exist at the base of the
intestinal crypts but also demonstrate the clear difficulties in using transgenic mouse
models to dissect sub-populations and functionality at a high level of detail.
Given the  striking ability  of  the  intestinal  epithelium to  regenerate,  a  natural
progression of recent research focus has been to understand which cell populations
are responsible for this behaviour. Theoretically there are two possible cell types res-
ponsible for regeneration; a distinct quiescent sub-population waiting to become
activated when required or a population that has one role during homeostasis but that
can revert to a stem-like state during injury i.e., plastic. The first named population
found to have a role in regeneration were Dll1 expressing crypt cells[16]. Using a com-
bination of lineage tracing in combination with irradiation the Clevers group found
that  during homeostasis  these cells  were proliferating secretory progenitors  but
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following irradiation and cell death they acquired stem cell capacity and were thus
capable of regenerating the injured epithelium. The question of what the apparently
quiescent +4 cell represented was further addressed by Doug Winton’s group using a
novel split-Cre mouse to conditionally genetically mark label-retaining cells (LRCs)[17].
Supporting the findings of the Clevers group this study found LRCs to be a slowly-
cycling Paneth and enteroendocrine cell progenitor that similarly reverted to a stem
cell-like fate during injury induced regeneration albeit at very low frequency - partly
due to the complexities of the transgenic model employed.
Following the finding of plasticity in Dll1 cells and LRCs, attention has focussed on
whether other populations can perform similar functions. Indeed, it has now been
shown that goblet cells, enteroendocrine cells, enterocytes and Paneth cells are all
capable of contextually acquiring stem cell capacity[9,18-28]. Analysis of these reports
however shows wide variation in the types of injury models employed varying from
relatively mild oral dextran sulfate sodium (DSS) that induces mucosal inflammation,
to  lethal  whole-body  irradiation  (12Gy),  making  it  difficult  to  compare  results
between studies (Table 1). More recently it has also been shown that some secretory
progenitor  populations even during homeostasis  may stochastically acquire ste-
mness[22,26,28].  This bi-fated character of some secretory progenitors was originally
demonstrated in 2004 where a small number of Ngn3 enteroendocrine cell progenitors
were also found to have clonal/stem cell capacity during homeostasis[29]. Whilst it is
entirely plausible that there are a wide range of cell types capable of plasticity there
are evidently those that cannot, as clone formation has never been found arising on
villi  even  during  classical  injury  induced  regeneration.  Schwitalla  et  al[30]  have
however demonstrated that aberrant elevated NF-kB signalling in apparently ter-
minally  differentiated  enterocytes  on  the  villi  can  cause  de-differentiation  to  a
tumour-initiating Lgr5+ status. This finding proposes that at the very least, if given a
strong enough stimulus, even terminally differentiated villus-based enterocytes may
acquire some stem cell characteristics.
Cumulatively, these studies show widespread plasticity amongst almost every cell
type described to-date in the murine intestinal epithelium however there are many
inconsistencies between studies driven primarily from the technical issues related to
ascribing identity and plasticity (Table 2). It could also be argued that the apparent
broadly found plasticity may not be relevant to advancing our understanding of what
cell types are actually at play in humans during routine epithelial insult. It has been
known for decades that cell types can be reprogrammed to different identities and
this forms the fundamental basis of induced pluripotent stem cells (iPS) technology.
In Waddington’s classical model of the epigenetic landscape of differentiation it is
therefore clear that cells can traverse between several deep valleys given the appro-
priate stimulus to ascend the elevations between[31]. Evidently, any cell type if pushed
hard enough can de-differentiate or trans-differentiate but the question remains what
represents a physiological injury and what cell types are involved in the subsequent
“homeostatic regeneration”? It may well be the case that during different forms of
injury such as that seen between Crohn’s disease and ulcerative colitis va-rying cell
types are mobilised via plasticity to the stem cell state to try and repair the damaged
epithelium.
How then can the field move forward to make meaningful in-roads into translating
these previous animal findings to the benefit of patients? There are two areas that
would seem ripe for development – tools for lineage tracing in humans and better
validated injury models in mice.  Lineage tracing in mice is  primarily performed
through generating transgenic mouse strains which is clearly impossible in humans.
There are however several new tools that could permit lineage tracing analysis in
human tissue albeit by quantifying the clonal output of all potentially clonogenic cells.
Two important recent reports have made use of next generation sequencing tech-
nology to identify clones through the quantification of somatically acquired mosaic
mutations  found  in  human  and  murine  tissue[32,33].  The  advances  now  made  in
sequencing technologies enabling combined single cell DNA (scDNAseq) and RNA
sequencing  (scRNAseq)  allow  for  similar  sequencing  approaches  with  higher
coverage to uncover cellular hierarchies from human tissue in both disease and home-
ostasis.
Clonal marking in humans can also be performed by quantifying mitochondrial
DNA (mtDNA) mutations through dual immunohistochemical (IHC) staining for the
mitochondrially  encoded enzyme cytochrome-c  oxidase  (CCO)[34].  Cells  acquire
mtDNA mutations infrequently and can be identified through this IHC technique as
cumulatively more are acquired in the many mtDNA copies of the CCO gene via
stochastic genetic drift. As the mutation is genetic and therefore heritable, the clonal
output of cells acquiring these mutations can be quantified. More recently several new
similarly working but genomic DNA (gDNA) encoded neutral IHC clonal marks have
been described by the Winton laboratory[35]. Importantly, both CCO staining and the
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Table 1  Mouse injury models used for plasticity studies
Study Plastic cell identified Injury model used
Tian et al[18] Bmi1+ cell DTR Lgr5+ ablation
Roth et al[19] Paneth cell 12Gy radiation
van Es et al[16] Dll1+ cell 6Gy radiation
Buczacki et al[17] Label-retaining cell 6Gy radiation, doxorubicin or hydroxyurea
Asfaha et al[20] Upper crypt progenitor 12Gy radiation +/- 5-Fluorouracil
Tetteh et al[27] Alpi1+ enterocyte DTR Lgr5+ ablation
Jadhav et al[9] Goblet cell progenitors DTR Lgr5+ ablation
Yan et al[21] Enteroendocrine cell 12Gy radiation
Ishibashi et al[22] Atoh1+ cell DSS (1.75%) for 5 d
Nusse et al[23] Lgr5- crypt cell Parasite infection
Schmitt et al[24] Paneth cell DSS (3%) for 1 wk
Tomic et al[26] Atoh1+ cell 6Gy radiation, AOM or 2% DSS
Yu et al[25] Lyz1+ Paneth cell 12Gy radiation
Castillo et al[28] Atoh1+ cell DSS (2.5%-3%) for 5 d
newer clonal marks allow the quantification of clonal behaviour in situ from human
tissue. Using these techniques on matched sections of diseased and normal tissue
allows an understanding, at the numerical level, of changes in behaviour such as seen
in plasticity. Further, combining these lineage tracing approaches with scRNAseq
could provide profound insights, like those described in the mouse, to understanding
intestinal homeostasis and plasticity in humans.
CONCLUSION
Finally, there is an urgent need to better define the cellular effects of common human
intestinal epithelial injuries to identify appropriate murine model equivalents. The
current use of multiple different forms of injury models which only bear a passing
relationship to human disease in that there is some degree of cell death is far from
ideal. The interplay between epithelial loss, stromal tissue, immune cells, vasculature
and resident microbiota is highly complex and very likely inadequately modelled in
our current simplistic models of injury performed on mice housed in clean animal
facilities. Here, the opposite approach to that presented earlier could be used: human
studies into the precise cellular events occurring during various injuries could inform
the development of better murine injury models. It would appear that the field is
reaching the limitations of what can be achieved with current tools and models and in
order to advance as rapidly as previously, new approaches are required that max-
imise on novel technologies and translationally relevant models.
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Table 2  Concepts leading to difficulties in ascribing behaviour to cell types in the intestine
CreER and Tamoxifen Toxicity
Off-target effects
Incongruity between reporter expression and protein expression Regional differences
Chronicity of reporter stability
Reporter and mRNA expression differences
Inconsistent injury models Intestinal specific effects including incomplete cell type eradication e.g.,
diphtheria toxin mediated cell death
Off-target whole body effects e.g., irradiation
Representative of “homeostatic regeneration”
Different cell-type responses to different injuries
Laboratory differences Microbiota
Diet
Area of intestine examined
Strain differences between laboratories due to inbreeding
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